IRIS publication 243943899
Metabolic Syndrome and Obesity in Adults
RIS format for Endnote and similar
TY - JOUR - Power, SE,Fitzgerald, GF,O'Toole, PW,Ross, RP,Stanton, C,Quigley, EMM,Murphy, EF,Guarino, A,Quigley, EMM,Walker, WA - 2013 - March - Probiotic Bacteria And Their Effect On Human Health And Well-Being - Metabolic Syndrome and Obesity in Adults - Validated - () - HIGH-FAT-DIET LACTOBACILLUS-GASSERI SBT2055 HUMAN GUT MICROBIOTA RANDOMIZED CONTROLLED-TRIAL INSULIN-RESISTANCE CARDIOVASCULAR-DISEASE ADIPOSE-TISSUE ADIPOCYTE SIZE MOUSE MODEL INTESTINAL MICROBIOTA - 107 - 103 - 121 - The relatively recent discovery that changes in the composition and metabolic activity of the gut microbiota are associated with obesity and related disorders has led to an explosion of interest in this now distinct research field. In the following chapter, we discuss the current evidence related to how the modulation of gut microbial populations might have beneficial effects with respect to controlling obesity. A number of studies in both animals and humans have shown that the composition of the gut microbiota is significantly altered in obesity and diabetes. Strategies including specific functional foods, probiotics, and prebiotics have the potential to favorably influence host metabolism by targeting the gut microbiota. Indeed, probiotics appear to be a promising approach to alter the host metabolic alterations linked to the changes in the gut microbiota. However, the mechanisms by which probiotics may impact on the development of obesity and metabolic health remain unclear and require further investigation. Copyright (c) 2013 S. Karger AG, Basel - 10.1159/000345750 DA - 2013/03 ER -
BIBTeX format for JabRef and similar
@article{V243943899, = {Power, SE and Fitzgerald, GF and O'Toole, PW and Ross, RP and Stanton, C and Quigley, EMM and Murphy, EF and Guarino, A and Quigley, EMM and Walker, WA }, = {2013}, = {March}, = {Probiotic Bacteria And Their Effect On Human Health And Well-Being}, = {Metabolic Syndrome and Obesity in Adults}, = {Validated}, = {()}, = {HIGH-FAT-DIET LACTOBACILLUS-GASSERI SBT2055 HUMAN GUT MICROBIOTA RANDOMIZED CONTROLLED-TRIAL INSULIN-RESISTANCE CARDIOVASCULAR-DISEASE ADIPOSE-TISSUE ADIPOCYTE SIZE MOUSE MODEL INTESTINAL MICROBIOTA}, = {107}, pages = {103--121}, = {{The relatively recent discovery that changes in the composition and metabolic activity of the gut microbiota are associated with obesity and related disorders has led to an explosion of interest in this now distinct research field. In the following chapter, we discuss the current evidence related to how the modulation of gut microbial populations might have beneficial effects with respect to controlling obesity. A number of studies in both animals and humans have shown that the composition of the gut microbiota is significantly altered in obesity and diabetes. Strategies including specific functional foods, probiotics, and prebiotics have the potential to favorably influence host metabolism by targeting the gut microbiota. Indeed, probiotics appear to be a promising approach to alter the host metabolic alterations linked to the changes in the gut microbiota. However, the mechanisms by which probiotics may impact on the development of obesity and metabolic health remain unclear and require further investigation. Copyright (c) 2013 S. Karger AG, Basel}}, = {10.1159/000345750}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Power, SE,Fitzgerald, GF,O'Toole, PW,Ross, RP,Stanton, C,Quigley, EMM,Murphy, EF,Guarino, A,Quigley, EMM,Walker, WA | ||
YEAR | 2013 | ||
MONTH | March | ||
JOURNAL_CODE | Probiotic Bacteria And Their Effect On Human Health And Well-Being | ||
TITLE | Metabolic Syndrome and Obesity in Adults | ||
STATUS | Validated | ||
TIMES_CITED | () | ||
SEARCH_KEYWORD | HIGH-FAT-DIET LACTOBACILLUS-GASSERI SBT2055 HUMAN GUT MICROBIOTA RANDOMIZED CONTROLLED-TRIAL INSULIN-RESISTANCE CARDIOVASCULAR-DISEASE ADIPOSE-TISSUE ADIPOCYTE SIZE MOUSE MODEL INTESTINAL MICROBIOTA | ||
VOLUME | 107 | ||
ISSUE | |||
START_PAGE | 103 | ||
END_PAGE | 121 | ||
ABSTRACT | The relatively recent discovery that changes in the composition and metabolic activity of the gut microbiota are associated with obesity and related disorders has led to an explosion of interest in this now distinct research field. In the following chapter, we discuss the current evidence related to how the modulation of gut microbial populations might have beneficial effects with respect to controlling obesity. A number of studies in both animals and humans have shown that the composition of the gut microbiota is significantly altered in obesity and diabetes. Strategies including specific functional foods, probiotics, and prebiotics have the potential to favorably influence host metabolism by targeting the gut microbiota. Indeed, probiotics appear to be a promising approach to alter the host metabolic alterations linked to the changes in the gut microbiota. However, the mechanisms by which probiotics may impact on the development of obesity and metabolic health remain unclear and require further investigation. Copyright (c) 2013 S. Karger AG, Basel | ||
PUBLISHER_LOCATION | |||
ISBN_ISSN | |||
EDITION | |||
URL | |||
DOI_LINK | 10.1159/000345750 | ||
FUNDING_BODY | |||
GRANT_DETAILS |